Selective β2-AR Antagonism in Asthma

NCT07272135 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: TR4
OTHER: Placebo

Sponsor

Trio Medicines Ltd.

Collaborators

[object Object]